RGNX Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Strong Sell

20

19 5 3

Oscillators

Sell

30

5 4 1

Moving averages

Strong Sell

15

14 1 2

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 6, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$620.36M

Growth and income

Eps-5.6

Free Cash Flow$-138.98M

Net Income$-90.05M

Profitability

Ebitda$-241.17M

Gross Profit$-4.68M

Balance sheet

Free Cash Flow$-138.98M

Total Assets$341.89M

Total Liabilities$320.81M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

FDMT4D MOLECULAR THERAPEUTICS IN+0.00%Market co-movement · Residual co-movement BEAMBEAM THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement PRMEPRIME MEDICINE INC+0.00%Market co-movement · Residual co-movement DNLIDENALI THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement CRSPCRISPR THERAPEUTICS AG+0.00%Market co-movement · Residual co-movement

RelationshipsLoading

REGENXBIO INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships